. Author manuscript; available in PMC: 2017 Oct 23.

Published in final edited form as: Osteoporos Int. 2017 Feb 2;28(5):1631–1640. doi: 10.1007/s00198-017-3916-4

Table 4.

Body composition measurements by DPP-4 activity

	β	SE	95% CI	p value
Total lean	−0.205^a	0.302	−0.797, 0.386	0.50
	0.116^b	0.167	−0.211, 0.443	0.49
	0.022^c	0.158	−0.289, 0.332	0.89
Percent lean	−0.4^a	0.291	−0.97, 0.17	0.17
	−0.112^b	0.211	−0.526, 0.302	0.60
	0.035^c	0.147	−0.253, 0.323	0.81
Total fat	0.271^a	0.288	−0.295, 0.836	0.35
	0.101^b	0.268	−0.423, 0.626	0.71
	−0.135^c	0.132	−0.394, 0.124	0.31
Percent fat	0.4^a	0.291	−0.17, 0.97	0.83
	0.112^b	0.211	−0.302, 0.526	0.56
	−0.035^c	0.147	−0.323, 0.253	0.59
Total mass	0.065^a	0.418	−0.755, 0.885	0.88
	0.217^b	0.371	−0.511, 0.945	0.56
	−0.114^c	0.21	−0.526, 0.299	0.59

Body composition measurements per increase of 0.1 AU of DPP-4 β beta, SE standard error of the beta, CI confidence interval

Unadjusted

Age, race, clinic site, gender

Age, race, clinic site, gender, smoking and alcohol use, BMI, change in BMI, frailty status, diabetes status, medication use, prevalent CHD, self-reported health